Cost-effectiveness of pertussis booster vaccination in the Netherlands.

Cost-effectiveness of pertussis booster vaccination in the Netherlands.

The aim of the current study is to estimate the epidemiological and economical consequences of several extended pertussis booster vaccination strategies and to explore the impact of parameters surrounded by large uncertainty on the cost-effectiveness. We developed an age structured transmission dyna...

Detaylı Bibliyografya
Asıl Yazarlar:	Rozenbaum, M, De Cao, E, Postma, M
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2012

Benzer Materyaller

Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around....
Yazar:: Rozenbaum, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.
Yazar:: Robin de Vries, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
Yazar:: Tu Hong Anh T, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
Yazar:: Hak Eelko, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
Yazar:: Evi van Schuppen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
Yazar:: Pauline Versteegen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination
Yazar:: Annieck M. Diks, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.
Yazar:: Sabine C de Greeff, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

Reemergence of Pertussis in the Highly Vaccinated Population of The Netherlands: Observations on Surveillance Data
Yazar:: Hester E. de Melker, ve diğerleri
Baskı/Yayın Bilgisi: (2000-08-01)

Pertussis in the Netherlands: an Outbreak Despite High Levels of Immunization with Whole-Cell Vaccine
Yazar:: H.E. de Melker, ve diğerleri
Baskı/Yayın Bilgisi: (1997-06-01)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
Yazar:: Sidsel Skou Voss, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Cost-Effectiveness of Pertussis Vaccination Schedule in Israel
Yazar:: Dean Langsam, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
Yazar:: Pauline Versteegen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
Yazar:: Saskia van der Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
Yazar:: Pauline Versteegen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
Yazar:: Joost J.M. Simons, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Pertussis Notification Rate and Tdpa Vaccine/Booster Coverage in Adults: An Opportunity for an Epidemiological Observatory in Primary Care
Yazar:: Francesco Lapi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?
Yazar:: Anouk T Urbanus, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy
Yazar:: Ricardo da Silva Antunes, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters
Yazar:: da Silva Antunes, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
Yazar:: I. A. Alekseeva, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

The Role of the Aceullular Pertussis Vaccine and the Comeback of 'Pertussis Pete'?
Yazar:: John M Conly, ve diğerleri
Baskı/Yayın Bilgisi: (2001-01-01)

Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
Yazar:: Cody Palmer, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
Yazar:: Aapo Knuutila, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Safety of pertussis vaccines for adolescents
Yazar:: M. P. Kostinov, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

New features of pertussis vaccination
Yazar:: A. P. Cherdantsev, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Insights into maternal pertussis vaccination counselling: a qualitative study on perspectives and experiences among midwives and gynaecologists in the Netherlands
Yazar:: Veja Widdershoven, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.
Yazar:: Hiltsje Hepkema, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Pertussis diagnostic practices of general practitioners in the Netherlands: A survey study
Yazar:: Jeanne Heil, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
Yazar:: Kelsey A. Gregg, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
Yazar:: Clara Maria Ausiello, ve diğerleri
Baskı/Yayın Bilgisi: (2014-07-01)

Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
Yazar:: E. M. Zaitsev, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
Yazar:: Geert Leroux-Roels, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study
Yazar:: Maarten M. Immink, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
Yazar:: Kacy S. Yount, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines
Yazar:: Punnee Pitisuttithum, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Burden of early, advanced and metastatic breast cancer in The Netherlands
Yazar:: G. T. Vondeling, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Acellular Pertussis Vaccine from Antigens of Freshly Isolated and Vaccine Strains of Bordetella pertussis with Different Genotypic Characteristics
Yazar:: E. M. Zaitsev, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Pertussis, anti-Bordetella pertussis toxin, vaccination, and clinical surveillance
Yazar:: Amnuay Kleebayoon, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
Yazar:: Kevin Markey, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)